CH625507A5 - - Google Patents
Download PDFInfo
- Publication number
- CH625507A5 CH625507A5 CH843780A CH843780A CH625507A5 CH 625507 A5 CH625507 A5 CH 625507A5 CH 843780 A CH843780 A CH 843780A CH 843780 A CH843780 A CH 843780A CH 625507 A5 CH625507 A5 CH 625507A5
- Authority
- CH
- Switzerland
- Prior art keywords
- methyl
- compound
- azidobenzoyl
- methoxy
- acid
- Prior art date
Links
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 17
- 150000001875 compounds Chemical class 0.000 description 13
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 9
- 230000037396 body weight Effects 0.000 description 8
- 229960000905 indomethacin Drugs 0.000 description 8
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- 241000700159 Rattus Species 0.000 description 5
- 239000002253 acid Substances 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 206010018691 Granuloma Diseases 0.000 description 4
- 241000699670 Mus sp. Species 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 150000002148 esters Chemical class 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- -1 p-azidobenzoyl halide Chemical class 0.000 description 3
- DCXHLPGLBYHNMU-UHFFFAOYSA-N 2-[1-(4-azidobenzoyl)-5-methoxy-2-methylindol-3-yl]acetic acid Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(N=[N+]=[N-])C=C1 DCXHLPGLBYHNMU-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- 230000009102 absorption Effects 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 150000001408 amides Chemical group 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 125000000852 azido group Chemical group *N=[N+]=[N-] 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 125000004185 ester group Chemical group 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 239000000155 melt Substances 0.000 description 2
- 229910052938 sodium sulfate Inorganic materials 0.000 description 2
- 235000011152 sodium sulphate Nutrition 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 2
- RLQZIECDMISZHS-UHFFFAOYSA-N 2-phenylcyclohexa-2,5-diene-1,4-dione Chemical compound O=C1C=CC(=O)C(C=2C=CC=CC=2)=C1 RLQZIECDMISZHS-UHFFFAOYSA-N 0.000 description 1
- XXKYTTAVNYTVFC-UHFFFAOYSA-N 4-azidobenzoyl chloride Chemical compound ClC(=O)C1=CC=C(N=[N+]=[N-])C=C1 XXKYTTAVNYTVFC-UHFFFAOYSA-N 0.000 description 1
- 235000009161 Espostoa lanata Nutrition 0.000 description 1
- 240000001624 Espostoa lanata Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- TXWGINUZLBAKDF-UHFFFAOYSA-N N-Deschlorobenzoyl indomethacin Chemical compound COC1=CC=C2NC(C)=C(CC(O)=O)C2=C1 TXWGINUZLBAKDF-UHFFFAOYSA-N 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- DXGTUUQHTDOFFQ-UHFFFAOYSA-N [N].C1=CC=C2NC=CC2=C1 Chemical group [N].C1=CC=C2NC=CC2=C1 DXGTUUQHTDOFFQ-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000010933 acylation Effects 0.000 description 1
- 238000005917 acylation reaction Methods 0.000 description 1
- 229910000102 alkali metal hydride Inorganic materials 0.000 description 1
- 150000008046 alkali metal hydrides Chemical class 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 239000000538 analytical sample Substances 0.000 description 1
- 230000003501 anti-edematous effect Effects 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000002917 arthritic effect Effects 0.000 description 1
- 125000003710 aryl alkyl group Chemical group 0.000 description 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 150000002475 indoles Chemical class 0.000 description 1
- 238000002329 infrared spectrum Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- JYUNCKSXPPDNRM-UHFFFAOYSA-N methyl 2-(5-methoxy-2-methyl-1h-indol-3-yl)acetate Chemical compound C1=C(OC)C=C2C(CC(=O)OC)=C(C)NC2=C1 JYUNCKSXPPDNRM-UHFFFAOYSA-N 0.000 description 1
- MGCHFHNFIVEJJC-UHFFFAOYSA-N methyl 2-[1-(4-azidobenzoyl)-5-methoxy-2-methylindol-3-yl]acetate Chemical compound COC(CC1=C(N(C2=CC=C(C=C12)OC)C(C1=CC=C(C=C1)N=[N+]=[N-])=O)C)=O MGCHFHNFIVEJJC-UHFFFAOYSA-N 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 229910000104 sodium hydride Inorganic materials 0.000 description 1
- 239000012312 sodium hydride Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 238000005809 transesterification reaction Methods 0.000 description 1
- 230000001562 ulcerogenic effect Effects 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/48—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
- A01N43/58—1,2-Diazines; Hydrogenated 1,2-diazines
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N47/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid
- A01N47/08—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having one or more single bonds to nitrogen atoms
- A01N47/10—Carbamic acid derivatives, i.e. containing the group —O—CO—N<; Thio analogues thereof
- A01N47/22—O-Aryl or S-Aryl esters thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D209/26—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an acyl radical attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D237/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pest Control & Pesticides (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Environmental Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Wood Science & Technology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dentistry (AREA)
- Plant Pathology (AREA)
- Agronomy & Crop Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pain & Pain Management (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Neurology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB20596/76A GB1531546A (en) | 1976-05-19 | 1976-05-19 | Anti-inflammatory indole derivative |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH625507A5 true CH625507A5 (en, 2012) | 1981-09-30 |
Family
ID=10148550
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH602677A CH620429A5 (en, 2012) | 1976-05-19 | 1977-05-13 | |
| CH843780A CH625507A5 (en, 2012) | 1976-05-19 | 1980-11-13 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH602677A CH620429A5 (en, 2012) | 1976-05-19 | 1977-05-13 |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US4181740A (en, 2012) |
| JP (1) | JPS6054957B2 (en, 2012) |
| AT (2) | AT353785B (en, 2012) |
| AU (1) | AU513192B2 (en, 2012) |
| BE (1) | BE854827A (en, 2012) |
| CA (1) | CA1072545A (en, 2012) |
| CH (2) | CH620429A5 (en, 2012) |
| DE (1) | DE2722399A1 (en, 2012) |
| DK (1) | DK215177A (en, 2012) |
| ES (1) | ES458764A1 (en, 2012) |
| FR (1) | FR2351960A1 (en, 2012) |
| GB (1) | GB1531546A (en, 2012) |
| GR (1) | GR63225B (en, 2012) |
| IE (1) | IE45061B1 (en, 2012) |
| IL (1) | IL51950A (en, 2012) |
| IN (1) | IN145784B (en, 2012) |
| LU (1) | LU77366A1 (en, 2012) |
| NL (1) | NL7704202A (en, 2012) |
| PH (1) | PH14095A (en, 2012) |
| YU (1) | YU39997B (en, 2012) |
| ZA (1) | ZA772468B (en, 2012) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS59204172A (ja) * | 1983-04-28 | 1984-11-19 | Kowa Co | アセメタシンの製造法 |
| DE3602670A1 (de) * | 1986-01-29 | 1987-07-30 | Speck Ulrich | Verwendung von n-acetylglucosamin zur therapie degenerativer gelenkprozesse und verwandter erkrankungen |
| KR940007001A (ko) * | 1992-09-16 | 1994-04-26 | 최승주 | 새로운 n-신나모일-2-메틸-5-메톡시-3-인돌 아세트산 에스테르, 그 제조방법 및 이를 함유하는 약학적 제제 |
| US20050004104A1 (en) * | 2003-05-30 | 2005-01-06 | Cali Brian M. | Methods for the protection of memory and cognition |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DD70880A (en, 2012) * | ||||
| FR1534460A (fr) * | 1966-08-25 | 1968-07-26 | Merck & Co Inc | Procédé de fabrication d'acides alpha-(1-aroyl-3-indolyl)-alcanoïques |
| BR6898229D0 (pt) * | 1967-04-11 | 1973-04-17 | Sumitomo Chemical Co | Processo para a producao de derivados do acido 1-cail-3-indolil-alifatico |
| DE2234651C3 (de) * | 1972-07-14 | 1978-11-09 | Troponwerke Gmbh & Co Kg, 5000 Koeln | Eckige Klammer auf l-(p-Chlorbenzoyl)-5-methoxy-2-methyl-3-indol] -acetoxj essigsaure, ihre Salze mit Basen, Verfahren zu ihrer Herstellung sowie pharmakologische Zubereitungen |
-
1976
- 1976-05-19 GB GB20596/76A patent/GB1531546A/en not_active Expired
-
1977
- 1977-04-16 IN IN585/CAL/77A patent/IN145784B/en unknown
- 1977-04-18 NL NL7704202A patent/NL7704202A/xx not_active Application Discontinuation
- 1977-04-22 AU AU24525/77A patent/AU513192B2/en not_active Expired
- 1977-04-25 ZA ZA00772468A patent/ZA772468B/xx unknown
- 1977-04-26 IL IL51950A patent/IL51950A/xx unknown
- 1977-05-06 CA CA277,824A patent/CA1072545A/en not_active Expired
- 1977-05-06 GR GR53389A patent/GR63225B/el unknown
- 1977-05-10 PH PH19756A patent/PH14095A/en unknown
- 1977-05-13 CH CH602677A patent/CH620429A5/fr not_active IP Right Cessation
- 1977-05-13 ES ES458764A patent/ES458764A1/es not_active Expired
- 1977-05-13 US US05/796,607 patent/US4181740A/en not_active Expired - Lifetime
- 1977-05-17 YU YU1231/77A patent/YU39997B/xx unknown
- 1977-05-17 FR FR7715027A patent/FR2351960A1/fr active Granted
- 1977-05-17 DK DK215177A patent/DK215177A/da not_active Application Discontinuation
- 1977-05-17 DE DE19772722399 patent/DE2722399A1/de not_active Withdrawn
- 1977-05-18 AT AT358077A patent/AT353785B/de not_active IP Right Cessation
- 1977-05-18 IE IE1028/77A patent/IE45061B1/en unknown
- 1977-05-18 JP JP52056519A patent/JPS6054957B2/ja not_active Expired
- 1977-05-18 BE BE177736A patent/BE854827A/xx not_active IP Right Cessation
- 1977-05-18 LU LU77366A patent/LU77366A1/xx unknown
-
1978
- 1978-03-09 AT AT171278A patent/AT358077B/de active
-
1980
- 1980-11-13 CH CH843780A patent/CH625507A5/fr not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| NL7704202A (nl) | 1977-11-22 |
| FR2351960B1 (en, 2012) | 1980-03-07 |
| ATA171278A (de) | 1980-01-15 |
| DK215177A (da) | 1977-11-20 |
| JPS6054957B2 (ja) | 1985-12-03 |
| AU2452577A (en) | 1978-10-26 |
| AU513192B2 (en) | 1980-11-20 |
| YU39997B (en) | 1985-06-30 |
| IE45061B1 (en) | 1982-06-16 |
| LU77366A1 (en, 2012) | 1977-08-29 |
| FR2351960A1 (fr) | 1977-12-16 |
| IN145784B (en, 2012) | 1978-12-16 |
| IL51950A (en) | 1980-09-16 |
| CH620429A5 (en, 2012) | 1980-11-28 |
| US4181740A (en) | 1980-01-01 |
| GB1531546A (en) | 1978-11-08 |
| YU123177A (en) | 1983-01-21 |
| AT358077B (de) | 1979-05-15 |
| DE2722399A1 (de) | 1977-12-01 |
| ZA772468B (en) | 1978-03-29 |
| GR63225B (en) | 1979-10-10 |
| AT353785B (de) | 1979-12-10 |
| CA1072545A (en) | 1980-02-26 |
| ATA358077A (de) | 1979-05-15 |
| BE854827A (fr) | 1977-09-16 |
| JPS537666A (en) | 1978-01-24 |
| PH14095A (en) | 1981-02-10 |
| ES458764A1 (es) | 1978-03-01 |
| IE45061L (en) | 1977-11-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0051023B1 (fr) | Nouveaux composés appartenant à la famille des benzoyl- et alpha-hydroxybenzyl-phényl-osides, leur procédé de préparation et leur application en thérapeutique | |
| FR2619109A1 (fr) | Acides sulfonamidothienylcarboxyliques a action therapeutique | |
| CH624952A5 (en, 2012) | ||
| CH639369A5 (fr) | Benzamides heterocycliques substitues et leurs procedes de preparation. | |
| CA1145752A (fr) | Procede de preparation de nouveaux derives du n'tetrahydropyridinyl-indoles et de leurs sels | |
| CA1139763A (fr) | Procede d'obtention de nouveaux aryltrifluoroethanols | |
| CH625507A5 (en, 2012) | ||
| BE779775A (fr) | Derives de l'uree, procede pour les preparer et leurs applications | |
| CA1217489A (fr) | Derives de la piperidine et leurs procedes de preparation | |
| EP0074873A1 (fr) | Dérivés de phénoxy-3 propanol-2, leur préparation et leur application en thérapeutique | |
| EP0176444B1 (fr) | Nouveau procédé de préparation de dérivés du 4 H-1,2-4-triazole, nouveaux triazoles ainsi obtenus, leur applicication comme médicaments et les compositions pharmaceutiques les renfermant | |
| FR2459219A1 (fr) | Derives d'acide alcanoique | |
| CH640818A5 (fr) | Derives d'acide naphtyl-1 acetique, leurs procedes de preparation et medicament les contenant. | |
| EP0728755B1 (fr) | Nouveaux composés du thiophène, leur procédé de préparation et les compositions pharmaceutiques les renfermant | |
| EP0002401B1 (fr) | Dérivés de naphtalène, leur préparation et leur application en thérapeutique | |
| CA1060020A (fr) | Procede de preparation de nouveaux derives de la dibenzo/b,c/ thiepine et leurs sels | |
| EP0061379B1 (fr) | Dérivés de pyridine, leur préparation et leur application en thérapeutique | |
| BE621255A (en, 2012) | ||
| CH334310A (fr) | Procédé de préparation de N-désacétyl-thiocolchicéines | |
| BE884145R (fr) | Composes indoliques nouveaux | |
| EP0153538B1 (fr) | Nouveaux dérivés de l'acide mélilotique, et médicaments les contenant | |
| BE877953A (fr) | Derives de la pyridoxine | |
| CH652386A5 (fr) | Derives d'acides phenyl aliphatique carboxyliques comme medicaments. | |
| BE862019R (fr) | Nouveaux derives de la vincamine, leur preparation et leur application comme medicaments | |
| CH627750A5 (fr) | Derives de la benzophenone, procede de preparation et compositions pharmaceutiques. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PL | Patent ceased | ||
| PL | Patent ceased |